Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 230.52B, Merck(MRK) trades at $92.86. The stock has a price-to-earnings ratio of 12.29 and currently yields dividends of 3.5%.
As of 2025-11-17, Merck(MRK) stock has fluctuated between $92.20 and $94.74. The current price stands at $92.86, placing the stock +0.7% above today's low and -2.0% off the high.
The Merck(MRK)'s current trading volume is 14.17M, compared to an average daily volume of 12.87M.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $105.07 at its peak.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $105.07 at its peak.
MRK News
BofA analyst Tim Anderson raised the firm’s price target on Merck (MRK) to $105 from $98 and keeps a Buy rating on the shares. The Cidara (CDTX) deal is a “reas...
Merck (MRK) said it anticipates a commercial opportunity surpassing $5B from Cidara’s (CDTX) experimental flu drug, and does not expect it to require a review b...
As of Nov. 17, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading de...
Analyst ratings
57%
of 28 ratingsMore MRK News
Merck (MRK) shares traded close to flat today, holding steady as investors weigh recent performance and updates from the pharmaceutical sector. Despite minimal...
Merck & Company, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Terence Flynn from Morgan Stanley maintained a Hold ra...
Insiders have been trading these 5 stocks: ((LLY)), ((GM)), ((IONQ)), ((MRK)) and ((MARA)). Here is a breakdown of their recent trades and their value. Meet Yo...
Close Key Takeaways Merck agreed to pay $9.2 billion to purchase Cidara Therapeutics, looking to cash in on the firm's experimental flu treatment. The $221.50...
(RTTNews) - Cidara Therapeutics, Inc. (CDTX) climbed 105.68% to $217.99, up $112.00, after it announced that Merck & Co. will acquire all outstanding shares for...
Cidara Therapeutics (CDTX) shares doubled, and then some, on Friday after Merck (MRK) agreed to buy the biotech company for $9.2 billion. The deal is "nothing...
Merck & Co. Inc. (NYSE:MRK) on Friday agreed to acquire Cidara Therapeutics, Inc. (NASDAQ:CDTX) for $221.50 per share in cash, for a total transaction value of...
